Antares Pharma
Investor Information
Antares Pharma
is a leading
developer
and
marketer
of
parenteral
pharmaceuticals.
Company Overview
Corporate
Products
Pipeline
Injector Technologies
Partners / Business Dev.
Investor Relations
News & Events
16 January 2012
Antares Pharma Enters Licensing Agreement with Daewoong Pharmaceuticals Co. LTD.
20 December 2011
Antares Pharma Enters Licensing Agreement with Pfizer Consumer Healthcare
12 December 2011
Antares Pharma to Present at the Oppenheimer 22nd Annual Healthcare Conference
8 December 2011
Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
29 November 2011
Antares Pharma Announces Issuance of New Libigel Patent
8 November 2011
Antares Q3 2011 Earnings
Our Jet-injectors, Auto-injectors and Pen injectors accommodate patients' increasing use of self-injectable medicines. The breadth of our injector platforms meets patient needs across many therapeutic settings.